MCID: IRR003
MIFTS: 47

Irritant Dermatitis

Categories: Skin diseases

Aliases & Classifications for Irritant Dermatitis

Summaries for Irritant Dermatitis

MalaCards based summary : Irritant Dermatitis, also known as dermatitis, irritant, is related to burns and dermatitis, atopic. An important gene associated with Irritant Dermatitis is IL1A (Interleukin 1 Alpha), and among its related pathways/superpathways are Allograft rejection and TRAF Pathway. The drugs Clobetasol and Glycerol have been mentioned in the context of this disorder. Affiliated tissues include testes, skin and eye.

Wikipedia : 76 Irritant contact dermatitis is a form of contact dermatitis that can be divided into forms caused by... more...

Related Diseases for Irritant Dermatitis

Diseases related to Irritant Dermatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 102)
# Related Disease Score Top Affiliating Genes
1 burns 30.3 IL1B TNF
2 dermatitis, atopic 30.0 FLG MS4A2 TNF
3 allergic contact dermatitis 30.0 FLG IL1B TNF
4 contact dermatitis 29.1 FLG IL1A IL1B KRT16 TNF
5 sebaceous gland disease 10.7 IER3IP1 IL1A
6 skin conditions 10.7 IL1A TNF
7 dermatitis 10.7
8 discoid lupus erythematosus 10.6 FLG KRT16
9 chronic follicular conjunctivitis 10.6 IL1A IL1B
10 melancholia 10.6 IER3IP1 TNF
11 esophagitis, eosinophilic, 1 10.6 FLG IER3IP1
12 dysentery 10.6 IER3IP1 IL1A
13 multidrug-resistant tuberculosis 10.6 IL1A TNF
14 post-transplant lymphoproliferative disease 10.6 IL1A TNF
15 limbal stem cell deficiency 10.5 IL1A IL1B
16 meningococcemia 10.5 IL1A IL1B
17 glossitis 10.5 IL1B KRT16
18 orofacial granulomatosis 10.5 FLG TNF
19 rosacea 10.5 IER3IP1 TNF
20 systemic onset juvenile idiopathic arthritis 10.5 IL1B TNF
21 staphylococcal toxic shock syndrome 10.5 IL1B TNF
22 autoimmune myocarditis 10.5 IL1B TNF
23 kashin-beck disease 10.5 IL1B TNF
24 vulvar vestibulitis syndrome 10.5 IL1B TNF
25 laryngitis 10.4 IL1B TNF
26 cerebral artery occlusion 10.4 IL1B TNF
27 haemophilus influenzae 10.4 IL1B TNF
28 retinitis pigmentosa 60 10.4 IL1B TNF
29 acute vascular insufficiency of intestine 10.4 IL1B TNF
30 actinic prurigo 10.4 IL1B TNF
31 poems syndrome 10.4 IL1B TNF
32 crohn's colitis 10.4 IL1B TNF
33 central nervous system vasculitis 10.4 IL1B TNF
34 osteosclerotic myeloma 10.4 IL1B TNF
35 cholesteatoma of middle ear 10.4 FLG IL1A KRT16
36 dental pulp disease 10.4 IL1B TNF
37 farmer's lung 10.4 PI3 TNF
38 pustular psoriasis 10.4 PI3 TNF
39 jejunoileitis 10.4 IL1B TNF
40 erysipelas 10.4 PI3 TNF
41 eales disease 10.3 IL1B TNF
42 root resorption 10.3 IL1A IL1B
43 blau syndrome 10.3 IL1B TNF
44 endometritis 10.3 IL1B TNF
45 pachyonychia congenita 1 10.3 FLG KRT16
46 scrub typhus 10.3 IL1B TNF
47 joint disorders 10.3 IL1B TNF
48 middle ear disease 10.3 IL1B TNF
49 epstein-barr virus-associated gastric carcinoma 10.3 FLG TNF
50 pleural disease 10.3 IL1B TNF

Graphical network of the top 20 diseases related to Irritant Dermatitis:



Diseases related to Irritant Dermatitis

Symptoms & Phenotypes for Irritant Dermatitis

Drugs & Therapeutics for Irritant Dermatitis

Drugs for Irritant Dermatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 72)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Clobetasol Approved, Investigational Phase 4 25122-46-7, 25122-41-2 32798 5311051
2
Glycerol Approved, Investigational Phase 4 56-81-5 753
3
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
4
Triamcinolone Approved, Vet_approved Phase 4,Phase 2 124-94-7 31307
5
Menthol Approved Phase 4 2216-51-5 16666
6
Zinc Approved, Investigational Phase 4,Not Applicable 7440-66-6 23994
7
Zinc oxide Approved Phase 4,Not Applicable 1314-13-2
8
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 1 22916-47-8 4189
9
Tocopherol Approved, Investigational, Nutraceutical Phase 4 1406-66-2 14986
10
Vitamin E Approved, Nutraceutical, Vet_approved Phase 4 59-02-9 14985
11 Anti-Inflammatory Agents Phase 4,Phase 2
12 Calcineurin Inhibitors Phase 4
13 glucocorticoids Phase 4,Phase 2
14 Hormone Antagonists Phase 4,Phase 2,Phase 1
15 Hormones Phase 4,Phase 2,Phase 1
16 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2,Phase 1
17 Immunosuppressive Agents Phase 4,Phase 2
18 Protective Agents Phase 4,Phase 2,Not Applicable
19 triamcinolone acetonide Phase 4,Phase 2
20 Triamcinolone diacetate Phase 4,Phase 2
21 Triamcinolone hexacetonide Phase 4,Phase 2
22 Antipruritics Phase 4
23 Dermatologic Agents Phase 4,Phase 1,Phase 2,Not Applicable
24 Micronutrients Phase 4,Not Applicable
25 Radiation-Protective Agents Phase 4,Phase 2,Not Applicable
26 Sunscreening Agents Phase 4,Phase 2,Not Applicable
27 Trace Elements Phase 4,Not Applicable
28 Antifungal Agents Phase 4,Phase 1
29 Anti-Infective Agents Phase 4,Phase 1
30 Cytochrome P-450 CYP2C9 Inhibitors Phase 4
31 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 1
32 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 1
33 Steroid Synthesis Inhibitors Phase 4,Phase 1
34 Antioxidants Phase 4
35 Tocopherols Phase 4
36 Tocotrienols Phase 4
37 Vitamins Phase 4
38 Aloe Nutraceutical Phase 4
39 Tocotrienol Investigational, Nutraceutical Phase 4 6829-55-6
40
Ephedrine Approved Phase 3 299-42-3 9294
41
Pseudoephedrine Approved Phase 3 90-82-4 7028
42
Timolol Approved Phase 3 26839-75-8 33624 5478
43
Maleic acid Experimental Phase 3 110-16-7 444266
44 Adrenergic Agents Phase 3
45 Adrenergic Antagonists Phase 3
46 Adrenergic beta-Antagonists Phase 3
47 Anti-Arrhythmia Agents Phase 3
48 Antihypertensive Agents Phase 3
49 Autonomic Agents Phase 3
50 Nasal Decongestants Phase 3

Interventional clinical trials:

(show all 37)
# Name Status NCT ID Phase Drugs
1 Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation Unknown status NCT00779792 Phase 4 clobetasol;triamcinolone acetonide;tacrolimus;glycerol;vehicle ointment (paraffin oil/soft white paraffin)
2 Trial Comparing Calmoseptine Ointment and Desitin Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants Unknown status NCT02716415 Phase 4 Calmoseptine Ointment;Destin Maximum Strength 40% Zinc
3 Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants Completed NCT00702507 Phase 4 0.25 % Miconazole Nitrate Ointment
4 Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash Completed NCT00219466 Phase 4
5 Determination of Safety and Consumers' Satisfaction of Moussik Versus Desitin Creamy Ointment in Diaper Rash Prophylaxis Withdrawn NCT01167465 Phase 4
6 Topical Timolol for Superficial Infantile Hemangioma Unknown status NCT01685398 Phase 3 0.5% timolol maleate eye drop;Normal saline
7 Mechlorethamine Induced Contact Dermatitis Avoidance Study Recruiting NCT03380026 Phase 2 Triamcinolone;Valchlor 0.016 % Topical Gel
8 COLLAGEN CROSS-LINKING WITH ULTRAVIOLET-A IN ASYMMETRIC CORNEAS Recruiting NCT03029104 Phase 2 CXLO Corneal Strengthening Solution and UVA Illumination
9 Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitises: HAL and BF-200 ALA Versus MAL Recruiting NCT02367547 Phase 1, Phase 2 Hexylaminolevulinate cream;Aminolevulinic Acid Nano Emulsion;Methylaminolevulinate cream
10 Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light Withdrawn NCT01256203 Phase 2 Solar Protection Formula SPF® 60
11 A 4-Day Study to Evaluate Phototoxicity of CCP-020 (Diacerein 1%) in Healthy Subjects Completed NCT03473184 Phase 1 CCP-020 Diacerein 1% topical ointment;Vehicle
12 A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects Completed NCT01293357 Phase 1 LEO 90105
13 A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity Completed NCT00353158 Phase 1 Doxycycline;Voriconazole
14 A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema Unknown status NCT01012453 Not Applicable
15 The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population Unknown status NCT02614248 Not Applicable
16 Regional Differences of Cutaneous Irritation and Its Effect on Skin Barrier Recovery Completed NCT03231813 Not Applicable
17 Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis Completed NCT00646867 Not Applicable
18 Risk Factors for Incontinence-Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence Completed NCT02996357
19 BM Collection From NICU Infants for Composition Completed NCT02570698
20 BM Characterization Pilot Completed NCT03138057
21 Infant Microbiome in Diaper Rash Completed NCT02893501
22 Human Phototoxicity Test (823/2016) Completed NCT02962856 Not Applicable BAY987517
23 18348-Human Phototoxicity Test Completed NCT02823483 Not Applicable
24 Test the Phototoxicity of Sunscreen Products Completed NCT02802930 Not Applicable SPF 50 Y65 110 (BAY987519);SPF 50 Y51 002 (BAY987519);SPF 15 V27 104 (BAY987519);Sodium chloride [NaCl]
25 Human Phototoxicity Test Completed NCT02754102 Not Applicable
26 Human Phototoxicity Test Completed NCT02751541 Not Applicable Sunscreen Sport Spray (BAY987519)
27 Human Phototoxicity Test Completed NCT02751489 Not Applicable
28 Human Phototoxicity Test Completed NCT02750475 Not Applicable Sunscreen Sport Lotion (BAY987516)
29 Prospective Single Center Randomized Double Blind Controlled Tolerability Trial of Six Hair Cleansing Conditioners Recruiting NCT03483025 Not Applicable
30 Comparison of Barrier Products in the Prevention of Incontinence-associated Dermatitis in Hospitalized Elderly Recruiting NCT03309059 Not Applicable
31 Prevention of Phototoxicities in Patients Undergoing Vemurafenib Treatment Recruiting NCT03108209 Not Applicable
32 Intervention to Reduce Diaper Need and Increase Use of Pediatric Preventive Care Not yet recruiting NCT03490045 Not Applicable
33 Preliminary Evaluation of CASTLE Barrier Prototype UK Terminated NCT01530087 Not Applicable
34 Comparison of Wash Wipes and Standard Care in the Prevention of Incontinence-associated Dermatitis in Elderly Terminated NCT02475512 Not Applicable
35 CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants Terminated NCT02299206 Not Applicable CeraVe Baby Diaper Rash Cream;Desitin Maximum Strength Original Paste
36 Vulvar Contact Dermatitis Resulting From Urine Incontinence Withdrawn NCT01320046
37 Diaper Distribution in Low-Income Infants Withdrawn NCT03425851 Not Applicable

Search NIH Clinical Center for Irritant Dermatitis

Cochrane evidence based reviews: dermatitis, irritant

Genetic Tests for Irritant Dermatitis

Anatomical Context for Irritant Dermatitis

MalaCards organs/tissues related to Irritant Dermatitis:

41
Testes, Skin, Eye

Publications for Irritant Dermatitis

Articles related to Irritant Dermatitis:

(show top 50) (show all 75)
# Title Authors Year
1
Immediate irritant dermatitis from the passionvine hopper (Scolypopa australis). ( 29869388 )
2018
2
Preapplication of white petroleum jelly to adjacent skin to prevent aluminum chloride-induced irritant dermatitis. ( 28619576 )
2017
3
Topical ROR inverse agonists suppress inflammation in mouse models of atopic dermatitis and acute irritant dermatitis. ( 28774591 )
2017
4
N-acyl ethanolamide and eicosanoid involvement in irritant dermatitis. ( 26947140 )
2016
5
To evaluate the efficacy and safety of "RV2427B" cream in Irritant dermatitis care. ( 23984228 )
2013
6
IL-6 deficiency exacerbates skin inflammation in a murine model of irritant dermatitis. ( 22966985 )
2013
7
Oxidative stress in allergic and irritant dermatitis: from basic research to clinical management. ( 22827837 )
2012
8
Allergic and irritant dermatitis: pathogenic and management aspects. ( 22827836 )
2012
9
Hand hygiene compliance and irritant dermatitis: a juxtaposition of healthcare issues. ( 22691060 )
2012
10
Contact irritant dermatitis in Kenya. ( 23472569 )
2012
11
Irritant Dermatitis to Staphylinid Beetle in Indian Troops in Congo. ( 27375320 )
2010
12
IL-6, VEGF, KC and RANTES are a major cause of a high irritant dermatitis to phthalic anhydride in C57BL/6 inbred mice. ( 20864798 )
2010
13
Povidone iodine irritant dermatitis. ( 20606840 )
2010
14
WOC nurse consult: Moist, painful peristomal skin. Chemical irritant dermatitis and pseudoverrucous lesions. ( 20228658 )
2010
15
Hair highlights and severe acute irritant dermatitis ("burn") of the scalp. ( 20854194 )
2010
16
Recurrent cyclic hyperkeratotic eczema after occupational alkali burn: traumatic chronic irritant dermatitis. ( 19489972 )
2009
17
Contact irritant dermatitis from insect secretions: report of 74 cases in a military unit in Eritrea. ( 19731793 )
2009
18
Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck. ( 18937664 )
2008
19
The effect of irritant dermatitis on cutaneous bioavailability of a metronidazole formulation, investigated by microdialysis and dermatopharmacokinetic method. ( 18537995 )
2008
20
Contact and primary irritant dermatitis of the nail unit diagnosis and treatment. ( 17403259 )
2007
21
Occlusive irritant dermatitis: when is "allergic" contact dermatitis not allergic? ( 17366682 )
2007
22
Moisturizer effect on irritant dermatitis: an overview. ( 16930228 )
2006
23
Effectiveness of a hand care regimen with moisturizer in manufacturing facilities where workers are prone to occupational irritant dermatitis. ( 15573643 )
2004
24
Irritant dermatitis to detergents in textiles. ( 12882025 )
2003
25
Irritant dermatitis due to prolonged contact with Oilatum Plus. ( 12534617 )
2003
26
Contact irritant dermatitis and anti-pruritic agents: the need to address the itch. ( 12852365 )
2003
27
Irritant dermatitis, irritancy and its role in allergic contact dermatitis. ( 11952708 )
2002
28
Sea water or its components alter experimental irritant dermatitis in man. ( 11301639 )
2001
29
Successfully managing incontinence-related irritant dermatitis across the lifespan. ( 10347509 )
1999
30
Crystal deodorant dermatitis: irritant dermatitis to alum-containing deodorant. ( 10431678 )
1999
31
Arachidonic acid metabolism in primary irritant dermatitis produced by patch testing of human skin with surfactants. ( 9875300 )
1998
32
Human barrier recovery after acute acetone perturbation: an irritant dermatitis model. ( 9667101 )
1998
33
Kerosene - Induced Acute Irritant Dermatitis (le). ( 20921732 )
1998
34
Predictive testing in contact dermatitis. Irritant dermatitis. ( 9255475 )
1997
35
What's new in irritant dermatitis. ( 9255463 )
1997
36
Pigmented and hyperkeratotic napkin dermatitis: a liquid detergent irritant dermatitis. ( 8864616 )
1996
37
Sodium hydroxide-induced irritant dermatitis as assessed by computerized elaboration of 20 MHz B-scan images and by TEWL measurement: a method for investigating skin barrier function. ( 7604663 )
1995
38
Electrical impedance measured to five skin depths in mild irritant dermatitis induced by sodium lauryl sulphate. ( 7772476 )
1995
39
Acute irritant dermatitis: effect of short-term topical corticoid treatment. ( 7587340 )
1995
40
Irritant dermatitis among workers cleaning up a pesticide spill: California 1991. ( 7793424 )
1995
41
Irritant dermatitis: experimental aspects. ( 9035907 )
1995
42
Irritant dermatitis in the workplace. ( 7923942 )
1994
43
The causes of irritant dermatitis. ( 8240913 )
1993
44
Moisturizers prevent irritant dermatitis. ( 1350143 )
1992
45
Susceptibility of atopic dermatitis patients to irritant dermatitis caused by sodium lauryl sulphate. ( 1681644 )
1991
46
Susceptibility to irritant dermatitis induced by sodium lauryl sulfate. ( 2365862 )
1990
47
Increased stratum corneum turnover induced by subclinical irritant dermatitis. ( 2369560 )
1990
48
Quantification of sodium lauryl sulfate irritant dermatitis in man: comparison of four techniques: skin color reflectance, transepidermal water loss, laser Doppler flow measurement and visual scores. ( 2774663 )
1989
49
Cumulative irritant dermatitis and abnormal epidermal plasminogen activator activity: what connection? ( 2531125 )
1989
50
Susceptibility to cumulative and acute irritant dermatitis. An experimental approach in human volunteers. ( 3180788 )
1988

Variations for Irritant Dermatitis

Expression for Irritant Dermatitis

Search GEO for disease gene expression data for Irritant Dermatitis.

Pathways for Irritant Dermatitis

Pathways related to Irritant Dermatitis according to GeneCards Suite gene sharing:

(show all 29)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.68 IL1A IL1B MS4A2 TNF
2
Show member pathways
12.3 IL1A IL1B TNF
3
Show member pathways
12.19 FLG KRT16 LCE2B PI3
4
Show member pathways
12.06 IL1A IL1B TNF
5
Show member pathways
12.06 IL1A IL1B TNF
6 12.04 IL1A IL1B TNF
7
Show member pathways
12.03 IL1A IL1B TNF
8
Show member pathways
12.01 IL1A IL1B TNF
9 11.96 IL1A IL1B TNF
10 11.88 IL1A IL1B TNF
11 11.82 IL1A IL1B TNF
12 11.78 IL1A IL1B TNF
13 11.74 IL1A IL1B TNF
14 11.67 IL1A IL1B TNF
15 11.64 IL1A IL1B TNF
16 11.59 IL1A IL1B TNF
17 11.46 IL1A IL1B TNF
18
Show member pathways
11.3 IL1A IL1B TNF
19 11.18 IL1B TNF
20 11.18 IL1A IL1B
21 11.13 IL1B TNF
22 11.12 IL1A IL1B TNF
23 11.11 IL1B TNF
24 10.99 IL1A IL1B TNF
25 10.91 IL1B TNF
26 10.75 IL1B TNF
27 10.68 IL1A IL1B TNF
28 10.28 IL1A IL1B TNF
29 10.21 IL1A IL1B

GO Terms for Irritant Dermatitis

Cellular components related to Irritant Dermatitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cornified envelope GO:0001533 8.8 FLG LCE2B PI3

Biological processes related to Irritant Dermatitis according to GeneCards Suite gene sharing:

(show all 32)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.91 IL1A IL1B MS4A2 TNF
2 positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123 9.79 IL1A IL1B TNF
3 cornification GO:0070268 9.76 FLG KRT16 PI3
4 epidermis development GO:0008544 9.75 FLG KRT16 LCE2B
5 keratinocyte differentiation GO:0030216 9.7 FLG KRT16 LCE2B
6 positive regulation of phagocytosis GO:0050766 9.65 IL1B TNF
7 extrinsic apoptotic signaling pathway in absence of ligand GO:0097192 9.65 IL1A IL1B
8 lipopolysaccharide-mediated signaling pathway GO:0031663 9.65 IL1B TNF
9 positive regulation of JNK cascade GO:0046330 9.65 IL1A IL1B TNF
10 positive regulation of cytokine secretion GO:0050715 9.64 IL1A TNF
11 positive regulation of interleukin-8 production GO:0032757 9.64 IL1B TNF
12 positive regulation of vascular endothelial growth factor production GO:0010575 9.63 IL1A IL1B
13 positive regulation of mitotic nuclear division GO:0045840 9.63 IL1A IL1B
14 positive regulation of interleukin-6 secretion GO:2000778 9.62 IL1B NLRP10
15 establishment of skin barrier GO:0061436 9.61 FLG KRT16
16 negative regulation of lipid catabolic process GO:0050995 9.6 IL1B TNF
17 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.59 IL1B TNF
18 peptide cross-linking GO:0018149 9.58 FLG LCE2B PI3
19 positive regulation of interleukin-2 biosynthetic process GO:0045086 9.57 IL1A IL1B
20 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.56 IL1B TNF
21 positive regulation of monocyte chemotactic protein-1 production GO:0071639 9.55 IL1A IL1B
22 positive regulation of chemokine biosynthetic process GO:0045080 9.54 IL1B TNF
23 ectopic germ cell programmed cell death GO:0035234 9.51 IL1A IL1B
24 positive regulation of interleukin-6 production GO:0032755 9.5 IL1A IL1B TNF
25 regulation of establishment of endothelial barrier GO:1903140 9.49 IL1B TNF
26 positive regulation of fever generation GO:0031622 9.46 IL1B TNF
27 fever generation GO:0001660 9.43 IL1A IL1B
28 sequestering of triglyceride GO:0030730 9.37 IL1B TNF
29 negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240 9.33 IL1A IL1B TNF
30 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.26 IL1B TNF
31 regulation of I-kappaB kinase/NF-kappaB signaling GO:0043122 9.13 IL1B NLRP10 TNF
32 inflammatory response GO:0006954 9.1 IL1A IL1B KRT16 MS4A2 NLRP10 TNF

Molecular functions related to Irritant Dermatitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 structural molecule activity GO:0005198 9.43 FLG KRT16 LCE2B
2 cytokine activity GO:0005125 9.33 IL1A IL1B TNF
3 interleukin-1 receptor binding GO:0005149 8.96 IL1A IL1B
4 structural constituent of epidermis GO:0030280 8.62 FLG PI3

Sources for Irritant Dermatitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....